Sort
146,196 grants matching “diabetes”
Development of marmoset models of neurodegenerative disease using embryonic stem cell-based gene-editing approaches
$728,786Kuo-Fen Lee · Salk Institute For Biological Studies · R24 · FY2019 · OD
High Deductible Health Plans and Receipt of Recommended Medical Care
$728,784Risha Gidwani Marszowski · University Of Colorado Denver · R01 · FY2024 · AG
Deciphering molecular details of cellular sugar transport and their roles in disease
$728,782Jeffrey S Abramson · University Of California Los Angeles · R35 · FY2022 · GM
Deciphering molecular details of cellular sugar transport and their roles in disease
$728,782Jeffrey S Abramson · University Of California Los Angeles · R35 · FY2021 · GM
Deciphering molecular details of cellular sugar transport and their roles in disease
$728,782Jeffrey S Abramson · University Of California Los Angeles · R35 · FY2023 · GM
Deciphering molecular details of cellular sugar transport and their roles in disease
$728,782Jeffrey S Abramson · University Of California Los Angeles · R35 · FY2024 · GM
Administrative Core
$728,767Joseph H. Szurszewski · Mayo Clinic Rochester · P01 · FY2012 · DK
Eye Determinants of Cognition (EyeDOC) Study
$728,748Alison G Abraham · Johns Hopkins University · R01 · FY2016 · AG
Delineating mechanisms of skeletal fragility in older adults with Type 1 Diabetes
$728,723Elaine Wei-Yin Yu · Massachusetts General Hospital · R01 · FY2022 · DK
Nonlipogenic ABCA1 inducers for ADRD
$728,720Gregory R J Thatcher · University Of Arizona · U01 · FY2025 · AG
Applying Mobile-Persuasive Technologies to Increase Physical Activity in Women
$728,709Yoshimi Fukuoka · University Of California, San Francisco · R01 · FY2010 · HL
Determination of the mechanistic targets of metformin
$728,707Akhilesh Basi Reddy · University Of Pennsylvania · DP1 · FY2024 · DK
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
$728,669Nora E Sarvetnick · University Of Nebraska Medical Center · R01 · FY2022 · AI
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
$728,669Nora E Sarvetnick · University Of Nebraska Medical Center · R01 · FY2021 · AI
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
$728,669Nora E Sarvetnick · University Of Nebraska Medical Center · R01 · FY2024 · AI
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study
$728,630Laurence Huang · University Of California, San Francisco · R01 · FY2017 · HL
Small molecules for perturbing iron homeostasis in bacterial biofilms
$728,617Mario Rivera · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2023 · AI
Targeting hepatic mitochondrial oxidation to treat NAFLD, NASH and type 2 diabetes
$728,612Gerald I Shulman · Yale University · R01 · FY2024 · DK
Calmodulin and Regulation of Cardiac Ryanodine Receptor and CaMKII
$728,602Donald M Bers · University Of California At Davis · R01 · FY2025 · HL
Identification of the Exposome in Fatty Liver Disease in Mexican American Families Using Genetic Correction
$728,588John Blangero · University Of Texas Rio Grande Valley · R01 · FY2021 · MD
Maternal High Fat Diet and Melanocortin System in Offspring
$728,583Kevin L Grove · Oregon Health & Science University · R01 · FY2008 · DK
Dyadic management of HIV cardiometabolic comorbidities among couples in Malawi
$728,566Amy Anne Conroy · University Of California, San Francisco · R01 · FY2022 · HL
Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD
$728,550Pamela Anne Maher · Virogenics, Inc. · R42 · FY2017 · AI
Defining Diabetes in Youth
$728,517University Of Colorado Denver · R01 · FY2004 · DK
Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands
$728,516Wilson Wong · Boston University (Charles River Campus) · R01 · FY2022 · DK